申请人:Fairhurst Robin Alec
公开号:US20140135330A1
公开(公告)日:2014-05-15
The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.
本发明涉及取代
嘧啶的
噁唑烷-2-酮化合物,其作为
PI3K(
磷脂酰肌醇-3-激酶)
抑制剂,以及其药用组合物、制备方法和用于治疗依赖于
PI3K的疾病、症状和疾病的用途。